Equibles does not estimate personal net worth.
Nethik Mohata has spoken on 1 earnings call across 1 company, most recently for Ind-Swift Laboratories Limited on August 17, 2026. The companies whose calls Nethik Mohata spoke on are classified in the Healthcare sector.
“So, my first question is regarding our existing portfolio. So, the statin combination drug had, you know, really boosted our numbers in FI26. So, is this drug also under some kind of partnership like the Viatris one or this is something that we are selling under our own brands?”
Ind-Swift Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended June 30, 2026
Ind-Swift Laboratories Limited
